M. Leuschner

1.5k total citations
38 papers, 1.1k citations indexed

About

M. Leuschner is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Leuschner has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 18 papers in Hepatology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Leuschner's work include Liver Disease Diagnosis and Treatment (14 papers), Gallbladder and Bile Duct Disorders (12 papers) and Liver Diseases and Immunity (10 papers). M. Leuschner is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Gallbladder and Bile Duct Disorders (12 papers) and Liver Diseases and Immunity (10 papers). M. Leuschner collaborates with scholars based in Germany, United States and United Kingdom. M. Leuschner's co-authors include U. Leuschner, W Kurtz, S. Güldutüna, K. Hübner, H Fischer, M. Gatzen, Günter Herrmann, Hanns Ackermann, K. Maier and H. H. Dahm and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

M. Leuschner

34 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Leuschner Germany 14 716 663 367 367 159 38 1.1k
S Iwatsuki United States 20 735 1.0× 426 0.6× 229 0.6× 743 2.0× 163 1.0× 47 1.3k
David S. Zimmon United States 15 357 0.5× 385 0.6× 286 0.8× 550 1.5× 357 2.2× 51 1.1k
A. de la Vega Spain 17 536 0.7× 462 0.7× 229 0.6× 334 0.9× 49 0.3× 38 1.0k
H. Bunzendahl Germany 15 825 1.2× 264 0.4× 209 0.6× 910 2.5× 69 0.4× 42 1.2k
Jan Petz United States 16 1.4k 1.9× 966 1.5× 247 0.7× 1.1k 3.0× 692 4.4× 18 1.9k
Ira Willner United States 16 706 1.0× 832 1.3× 100 0.3× 457 1.2× 198 1.2× 31 1.4k
Rodrigo Zapata Chile 12 336 0.5× 266 0.4× 192 0.5× 259 0.7× 49 0.3× 41 695
Padaki Nagaraja Rao India 19 507 0.7× 625 0.9× 85 0.2× 306 0.8× 73 0.5× 77 1.1k
Alec Avgerinos Greece 23 775 1.1× 713 1.1× 172 0.5× 870 2.4× 273 1.7× 57 1.6k
Rick Selby United States 16 346 0.5× 231 0.3× 306 0.8× 490 1.3× 237 1.5× 42 967

Countries citing papers authored by M. Leuschner

Since Specialization
Citations

This map shows the geographic impact of M. Leuschner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Leuschner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Leuschner more than expected).

Fields of papers citing papers by M. Leuschner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Leuschner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Leuschner. The network helps show where M. Leuschner may publish in the future.

Co-authorship network of co-authors of M. Leuschner

This figure shows the co-authorship network connecting the top 25 collaborators of M. Leuschner. A scholar is included among the top collaborators of M. Leuschner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Leuschner. M. Leuschner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leuschner, M., et al.. (2019). The sore throat: a clinical approach to tonsillopharyngitis. SHILAP Revista de lepidopterología. 61(4). 19–21. 1 indexed citations
2.
Leuschner, M., et al.. (2018). Non-technical skills training in the operating theatre: A meta-analysis of patient outcomes. The Surgeon. 17(4). 233–243. 23 indexed citations
3.
Petersen, Jörg, R Heyne, Stefan Mauss, et al.. (2015). Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany. Digestive Diseases and Sciences. 61(10). 3061–3071. 34 indexed citations
4.
Petersen, J., R Heyne, JF Schlaak, et al.. (2014). O122 EFFECTIVENESS OF TENOFOVIR DF FOR CHRONIC HEPATITIS B IN FIELD PRACTICE – 3 YEAR FINAL RESULTS FROM THE PROSPECTIVE GERMAN MULTICENTER NON-INTERVENTIONAL STUDY. Journal of Hepatology. 60(1). S51–S51. 3 indexed citations
5.
Petersen, John Asger, R Heyne, JF Schlaak, et al.. (2013). 768 EFFECTIVENESS OF TENOFOVIR FOR CHRONIC HEPATITIS B IN FIELD PRACTICE – 2 YEAR INTERIM RESULTS FROM THE PROSPECTIVE GERMAN MULTICENTER NON-INTERVENTIONAL STUDY (GEMINIS). Journal of Hepatology. 58. S313–S313. 5 indexed citations
6.
Güldutüna, S., A. Hellstern, M. Leuschner, et al.. (2008). Endoskopie, Stoßwellenlithotripsie und lokale Lyse bei komplizierten Pigmentsteinen der extra- und intrahepatischen Gallengänge. DMW - Deutsche Medizinische Wochenschrift. 116(8). 288–293.
7.
Leuschner, M., et al.. (2006). 13C-methacetin and13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis. Scandinavian Journal of Gastroenterology. 41(11). 1336–1341. 26 indexed citations
8.
Leuschner, M., et al.. (2002). The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid. European Journal of Gastroenterology & Hepatology. 14(12). 1369–1376. 15 indexed citations
9.
Güldutüna, S., et al.. (1999). The effect of bile salts and calcium on isolated rat liver mitochondria. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1453(3). 396–406. 21 indexed citations
10.
Leuschner, M., et al.. (1996). Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. Journal of Hepatology. 25(1). 49–57. 86 indexed citations
11.
Leuschner, U., et al.. (1994). Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis. Journal of Hepatology. 21(4). 624–633. 32 indexed citations
12.
Leuschner, U., et al.. (1994). Manual and automatic gallstone dissolution with methyltert-butyl ether. Digestive Diseases and Sciences. 39(6). 1302–1308. 6 indexed citations
13.
Leuschner, M. & U. Leuschner. (1992). Diagnostic Laparoscopy in Focal Parenchymal Disease of the Liver. Endoscopy. 24(8). 689–692. 6 indexed citations
14.
Schmidt, Klaus D., M. Leuschner, Alan G. Harris, et al.. (1992). Gallstones in acromegalic patients undergoing different treatment regimens. Journal of Molecular Medicine. 70(7). 556–9. 6 indexed citations
15.
Leuschner, U., et al.. (1991). Gallstone dissolution with methyltert-butyl ether in 120 patients?Efficacy and safety. Digestive Diseases and Sciences. 36(2). 193–199. 46 indexed citations
16.
Leuschner, U., et al.. (1991). Direct contact dissolution of gallbladder stones with methyl tert-butyl ether: experience in 209 patients.. PubMed. 26. 199–201. 2 indexed citations
18.
Leuschner, M., et al.. (1990). Gall stone dissolution with methyl tert-butyl ether: how to avoid complications.. Gut. 31(8). 922–925. 11 indexed citations
19.
Leuschner, U., H Fischer, W Kurtz, et al.. (1989). Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trial. Gastroenterology. 97(5). 1268–1274. 303 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026